Taken together, while these studies demonstrate that CCR7 seems to reliably predict the presence of lymph node metastases in more aggressive breast tumors, it is unclear whether CCR7 can be linked to patient survival in all breast cancers. This evidence concerns the gene CCR7 and breast cancer.